Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOral Presentations - Physicians/Scientists/Pharmacists

Radiolabeling of progenitor and stem cells with different technetium-99m nanocolloids

Winfried Brenner, Dagmara Niedzielska, Ralph Buchert, K Kompisch, Christina Rogge, Wolfram Zimmermann and Udo Schumacher
Journal of Nuclear Medicine May 2006, 47 (suppl 1) 70P;
Winfried Brenner
1Department of Nuclear Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dagmara Niedzielska
1Department of Nuclear Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ralph Buchert
1Department of Nuclear Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
K Kompisch
2Department of Anatomy II: Experimental Morphology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christina Rogge
3Institute of Experimental and Clinical Pharmacology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wolfram Zimmermann
3Institute of Experimental and Clinical Pharmacology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Udo Schumacher
2Department of Anatomy II: Experimental Morphology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

197

Objectives: Due to an increasing use of stem and progenitor cells (PCs) in cardiac phase I/II cell therapy studies, monitoring of transplanted PCs gains clinical interest. So far, the most commonly applied tracers have significant disadvantages such as radiotoxicity and high cellular efflux in case of In-111-oxine, and low cellular uptake in many PC subtypes and a short half-life in case of F-18-FDG. Since most PCs are able to phagocytose nanoparticles such as superparamagnetic iron oxide, as used for MR imaging, the aim of our study was to investigate the possibilities of labeling PCs by incubation with various commercially available radiocolloids.

Methods: For the labeling experiments we used human mesenchymal stem cells (MSCs), human processed lipoaspirate cells (PLACs), and murine embryonic stem cells (MES). 100.000-500.000 cells per well were incubated for 3-9 h with 500 kBq Tc-99m nanocolloids of different sizes and compositions: albumin colloids with a mean diameter of 7-14 nm (Nanocoll) and 205 nm (Senti-Scint) as well as tin colloid with a mean diameter of 140-280 nm (Amerscan tin colloid). After stopping the incubation, cellular retention of Tc-99m tin colloid was measured up to 27 h.

Results: The relative uptake of Nanocoll in MSCs (in % per 1 million cells, n = 3 each) after 3, 6, and 9 h of incubation was 0.5 ± 0.3%, 0.7 ± 0.4%, and 1.1 ± 1.0% (mean ± 1 SD), respectively. The respective values in PLACs were 0.3 ± 0.1%, 0.5 ± 0.2%, and 0.5 ± 0.2%. For Senti-Scint relative uptake was 0.2 ± 0.1%, 0.4 ± 0.4%, and 0.5 ± 0.5% in MSCs, and 0.2 ± 0.1%, 1.8 ± 0.3%, and 0.4 ± 0.3% in PLACs. The highest uptake values were found for tin colloid reaching 2.8 ± 1.5% after 3 h, 5.5 ± 2.5% after 6 h, and 7.1 ± 4.8% after 9 h in MSCs, and 7.7 ± 2.9%, 17.6 ± 3.7%, and 28.0 ± 11.4% in PLACs, respectively. In MES, uptake of tin colloid was 2.8 ± 0.6% after 3 h of incubation. Cellular retention of Tc-99m tin colloid up to 27 h after the end of incubation was higher than 95% in both MSCs and PLACs (n = 5 each) indicating no significant loss out of the cells.

Conclusions: Albumin colloids did not show relevant uptake in progenitor cells irrespectively of their particle size. Inert Tc-99m labeled tin colloid, however, yielded a sufficiently high and incubation time-dependent uptake as well as a stable cellular retention. Radiolabeled tin colloid, therefore, seems to be a promising tracer for stem cell labeling and imaging.

  • Society of Nuclear Medicine, Inc.
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 47, Issue suppl 1
May 1, 2006
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Radiolabeling of progenitor and stem cells with different technetium-99m nanocolloids
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Radiolabeling of progenitor and stem cells with different technetium-99m nanocolloids
Winfried Brenner, Dagmara Niedzielska, Ralph Buchert, K Kompisch, Christina Rogge, Wolfram Zimmermann, Udo Schumacher
Journal of Nuclear Medicine May 2006, 47 (suppl 1) 70P;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Radiolabeling of progenitor and stem cells with different technetium-99m nanocolloids
Winfried Brenner, Dagmara Niedzielska, Ralph Buchert, K Kompisch, Christina Rogge, Wolfram Zimmermann, Udo Schumacher
Journal of Nuclear Medicine May 2006, 47 (suppl 1) 70P;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oral Presentations - Physicians/Scientists/Pharmacists

  • 2-Arylbenzothiazole derivatives for beta-amyloid plaque imaging
  • Early stage assessment of intrabronchial valve placement by Xe ventilation/Tc MAA perfusion scintigraphy in patients with severe emphysema
  • Impact of naloxone-3-glucuronide (NXG) on small bowel (SBT) and colon transit time (CTT) in healthy volunteers under morphine
Show more Oral Presentations - Physicians/Scientists/Pharmacists

Cardiovascular Track

  • To Evaluated the Cardiac Function of Patients with Acute Myocardial Infarction by the Volume and Filling Curve of 99mTc-MIBI SPECT Myocardial Perfusion Imaging
  • Standard versus low-dose rubidium-82 dynamic positron emission tomography imaging with scanner-dependent bias correction for myocardial perfusion imaging and blood flow quantification
  • Evaluation of sympathetic function with PET 11C-hydroxyephedrine (HED) and ammonia (13N-NH3) in a canine pacing model of atrial fibrillation
Show more Cardiovascular Track

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire